{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:33:07Z","timestamp":1768008787993,"version":"3.49.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,12,1]]},"DOI":"10.1093\/jac\/dkh460","type":"journal-article","created":{"date-parts":[[2004,10,28]],"date-time":"2004-10-28T00:13:44Z","timestamp":1098922424000},"page":"1096-1102","source":"Crossref","is-referenced-by-count":26,"title":["Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis"],"prefix":"10.1093","volume":"54","author":[{"given":"Jill P.","family":"Adler-Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon A.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Proffitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,12]]},"reference":[{"key":"key\n\t\t\t\t20171013020839_R1","doi-asserted-by":"crossref","unstructured":"Pappas, P. G., Rex, J. H., Sobel, J. D. et al. (2004). Guidelines for treatment of candidiasis. Clinical Infectious Diseases38, 161\u201389.","DOI":"10.1086\/380796"},{"key":"key\n\t\t\t\t20171013020839_R2","doi-asserted-by":"crossref","unstructured":"Bowden, R., Chandrasekar, P., White, M. H. et al. (2002). A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. Clinical Infectious Diseases35, 359\u201366.","DOI":"10.1086\/341401"},{"key":"key\n\t\t\t\t20171013020839_R3","doi-asserted-by":"crossref","unstructured":"Wong-Beringer, A., Jacobs, R. A. & Guglielmo, B. J. (1998). Lipid formulations of amphotericin B, clinical efficacy and toxicities. Clinical Infectious Diseases27, 603\u201318.","DOI":"10.1086\/514704"},{"key":"key\n\t\t\t\t20171013020839_R4","doi-asserted-by":"crossref","unstructured":"Ostrosky-Zeichner, L., Marr, K. A., Rex, J. H. et al. (2003). Amphotericin B: time for a new \u2018gold standard\u2019. Clinical Infectious Diseases37, 415\u201325.","DOI":"10.1086\/376634"},{"key":"key\n\t\t\t\t20171013020839_R5","doi-asserted-by":"crossref","unstructured":"Walsh, T. J., Finberg, R. W., Arndt, C. et al. (1999). Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine340, 764\u201371.","DOI":"10.1056\/NEJM199903113401004"},{"key":"key\n\t\t\t\t20171013020839_R6","doi-asserted-by":"crossref","unstructured":"Hiemenz, J. W. & Walsh, T. J. (1998). Lipid formulations of amphotericin B. Journal of Liposome Research8, 443\u201367.","DOI":"10.3109\/08982109809039931"},{"key":"key\n\t\t\t\t20171013020839_R7","doi-asserted-by":"crossref","unstructured":"Wingard, J. R., White, M. H., Anaissie, E. et al. (2000). A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clinical Infectious Diseases31, 1155\u201363.","DOI":"10.1086\/317451"},{"key":"key\n\t\t\t\t20171013020839_R8","doi-asserted-by":"crossref","unstructured":"Pasic, S., Flannagan, L. & Cant, A. (1997). Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiency. Bone Marrow Transplantation19, 1229\u201332.","DOI":"10.1038\/sj.bmt.1700821"},{"key":"key\n\t\t\t\t20171013020839_R9","doi-asserted-by":"crossref","unstructured":"Sundar, S., Jha, T. K., Thakur, C. P. et al. (2003). Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study. Clinical Infectious Diseases37, 800\u20134.","DOI":"10.1086\/377542"},{"key":"key\n\t\t\t\t20171013020839_R10","doi-asserted-by":"crossref","unstructured":"Walsh, T. J., Goodman, J. L., Pappas, P. et al. (2001). Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrobial Agents and Chemotherapy45, 3487\u201396.","DOI":"10.1128\/AAC.45.12.3487-3496.2001"},{"key":"key\n\t\t\t\t20171013020839_R11","unstructured":"Adler-Moore, J. & Proffitt, R. T. (2003). Effect of tissue penetration on AmBisome efficacy. Current Opinion in Investigational Drugs4, 179\u201385."},{"key":"key\n\t\t\t\t20171013020839_R12","doi-asserted-by":"crossref","unstructured":"Walsh, T. J., Yeldandi, V., McEvoy, M. et al. (1998). Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrobial Agents and Chemotherapy42, 2391\u20138.","DOI":"10.1128\/AAC.42.9.2391"},{"key":"key\n\t\t\t\t20171013020839_R13","doi-asserted-by":"crossref","unstructured":"Boswell, G. W., Buell, D. & Bekersky, I. (1998). AmBisome (liposomal amphotericin B): a comparative review. Journal of Clinical Pharmacology38, 583\u201392.","DOI":"10.1002\/j.1552-4604.1998.tb04464.x"},{"key":"key\n\t\t\t\t20171013020839_R14","doi-asserted-by":"crossref","unstructured":"Groll, A. H., Giri, N., Petraitis, V. et al. (2000). Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. Journal of Infectious Diseases182, 274\u201382.","DOI":"10.1086\/315643"},{"key":"key\n\t\t\t\t20171013020839_R15","doi-asserted-by":"crossref","unstructured":"Garcia, A., Adler-Moore, J. P. & Proffitt, R. T. (2000). Single-dose AmBisome (liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis. Antimicrobial Agents and Chemotherapy44, 2327\u201332.","DOI":"10.1128\/AAC.44.9.2327-2332.2000"},{"key":"key\n\t\t\t\t20171013020839_R16","unstructured":"Groll, A. H., Mickiene, D., Petraitis, R. et al. (2001). Disposition and efficacy of amphotericin B formulations in a kidney target model of invasive candidiasis. In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2001. Abstract J-1607, p 389. American Society for Microbiology, Washington, DC, USA."},{"key":"key\n\t\t\t\t20171013020839_R17","doi-asserted-by":"crossref","unstructured":"Clemons, K. V., Sobel, R. A., Williams, P. L. et al. (2002). Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrobial Agents and Chemotherapy46, 2420\u20136.","DOI":"10.1128\/AAC.46.8.2420-2426.2002"},{"key":"key\n\t\t\t\t20171013020839_R18","unstructured":"Albert, M. M., Stahl-Carroll, L., Luther, M. F. et al. (1995). Comparison of liposomal amphotericin B to amphotericin B for treatment of murine cryptococcal meningitis. Journal of Mycological Medicine5, 1\u20136."},{"key":"key\n\t\t\t\t20171013020839_R19","doi-asserted-by":"crossref","unstructured":"Graybill, J. R. & Bocanegra, R. (1995). Liposomal amphotericin B therapy of murine histoplasmosis. Antimicrobial Agents and Chemotherapy39, 1885\u20137.","DOI":"10.1128\/AAC.39.8.1885"},{"key":"key\n\t\t\t\t20171013020839_R20","doi-asserted-by":"crossref","unstructured":"Glasmacher, A., Hahn, C., Molitorm, E. et al. (1999). Itraconazole through concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules. Mycoses42, 591\u2013600.","DOI":"10.1046\/j.1439-0507.1999.00518.x"},{"key":"key\n\t\t\t\t20171013020839_R21","doi-asserted-by":"crossref","unstructured":"Johnson, M. D. & Perfect, J. R. (2003). Caspofungin: first approved agent in a new class of antifungals. Expert Opinion in Pharmacotherapy4, 807\u201323.","DOI":"10.1517\/14656566.4.5.807"},{"key":"key\n\t\t\t\t20171013020839_R22","doi-asserted-by":"crossref","unstructured":"Cornely, O. A., Schmitz, K. & Aisenbrey, S. (2002). The first echinocandin: caspofungin. Mycoses45, Suppl. 3, 56\u201360.","DOI":"10.1111\/j.1439-0507.2002.tb04771.x"},{"key":"key\n\t\t\t\t20171013020839_R23","doi-asserted-by":"crossref","unstructured":"Buisman, A. M., Van Zwet, T. L., Langermans, J. A. et al. (1999). Different effect of granulocyte colony-stimulating factor or bacterial infection on bone-marrow cells of cyclophosphamide-treated or irradiated mice. Immunology97, 601\u201310.","DOI":"10.1046\/j.1365-2567.1999.00835.x"},{"key":"key\n\t\t\t\t20171013020839_R24","doi-asserted-by":"crossref","unstructured":"Leunk, R. D. & Moon, R. J. (1979). Physiological and metabolic alterations accompanying systemic candidiasis in mice. Infection and Immunity26, 1035\u201341.","DOI":"10.1128\/IAI.26.3.1035-1041.1979"},{"key":"key\n\t\t\t\t20171013020839_R25","doi-asserted-by":"crossref","unstructured":"Rogers, T. R. (2001). Optimal use of existing and new antifungal drugs. Current Opinion in Critical Care7, 238\u201341.","DOI":"10.1097\/00075198-200108000-00005"},{"key":"key\n\t\t\t\t20171013020839_R26","doi-asserted-by":"crossref","unstructured":"Gangneux, J. P., Sulahian, A., Garin, Y. J. et al. (1996). Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome. Antimicrobial Agents and Chemotherapy40, 1214\u20138.","DOI":"10.1128\/AAC.40.5.1214"},{"key":"key\n\t\t\t\t20171013020839_R27","doi-asserted-by":"crossref","unstructured":"Allen, S. D., Sorensen, K. N., Nejdl, M. J. et al. (1994). Prophylactic efficacy of aerosolized liposomal (AmBisome) and non liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis. Journal of Antimicrobial Chemotherapy34, 1001\u201313.","DOI":"10.1093\/jac\/34.6.1001"},{"key":"key\n\t\t\t\t20171013020839_R28","doi-asserted-by":"crossref","unstructured":"Gilbert, B. E. & Proffitt, R. (1996). Aerosolized AmBisome treatment of pulmonary Cryptococcus neoformans infection in mice. Journal of Aerosol Medicine9, 263\u201376.","DOI":"10.1089\/jam.1996.9.263"},{"key":"key\n\t\t\t\t20171013020839_R29","doi-asserted-by":"crossref","unstructured":"van Etten, E. W. M., van den Heuvel-de Groot, C. & Bakker-Woudenberg, I. A. (1993). Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice. Journal of Antimicrobial Chemotherapy32, 723\u201339.","DOI":"10.1093\/jac\/32.5.723"},{"key":"key\n\t\t\t\t20171013020839_R30","unstructured":"Adler-Moore, J. (1994). AmBisome targeting to fungal infections. Bone Marrow Transplantation14, Suppl. 5, S3\u2013S7."},{"key":"key\n\t\t\t\t20171013020839_R31","doi-asserted-by":"crossref","unstructured":"Lee, J. W., Amantea, M. A., Francis, P. A. et al. (1994). Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. Antimicrobial Agents and Chemotherapy38, 713\u20138.","DOI":"10.1128\/AAC.38.4.713"},{"key":"key\n\t\t\t\t20171013020839_R32","doi-asserted-by":"crossref","unstructured":"Boswell, G. W., Bekersky, I., Buell, D. et al. (1998). Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats. Antimicrobial Agents and Chemotherapy42, 263\u20138.","DOI":"10.1128\/AAC.42.2.263"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/54\/6\/1096\/2542607\/dkh460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T01:23:52Z","timestamp":1624757032000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/54\/6\/1096\/856035\/Alternative-dosing-regimens-of-liposomal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,12]]},"published-print":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh460","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,12]]},"published":{"date-parts":[[2004,12,1]]}}}